Quantcast

Latest Anti-diabetic medication Stories

2014-07-21 23:09:32

The Actos Lawsuit Filed on Behalf of a NY Man Who Developed Baldder Cancer Alleges Takedea Pharmaceuticals America Inc., Knew Their Diabetic Medication Caused Bladder Cancer But Did Not Inform Doctors and Patients Columbus, OH (PRWEB) July 21, 2014 The defective drug attorneys at Wright & Schulte LLC have filed an Actos lawsuit on behalf of a Schenectady, New York man who alleges that he developed bladder cancer as a result of taking Actos for more than a year to treat his Type II...

Eating Whey Protein Before Meals Could Improve Blood Glucose Control: Study
2014-07-08 03:43:09

Diabetologia New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that consuming whey protein before a regular breakfast reduces the blood sugar spikes seen after meals and also improves the body's insulin response. Thus whey protein could be an additional tool to help control blood sugar in patients with diabetes. The research was conducted in Israel by Professor Daniela Jakubowicz and Dr Julio Wainstein (Wolfson Medical...

Insulin May Do More Harm Than Good For Some Patients With Type 2 Diabetes
2014-07-01 03:23:59

University of Michigan Health System Harm to quality of life outweighs benefits of treatment for older patients and those with negative feelings about side effects, burden of medication For patients with type 2 diabetes – especially those over age 50 – the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs, says a new study by the University of Michigan Health System, the VA Ann Arbor Healthcare System, and...

Afrezza Inhalation Powder
2014-06-29 04:56:44

April Flowers for redOrbit.com - Your Universe Online Treatment options for diabetes come in a wide variety, ranging from oral medications to insulin pumps. USA Today reports that a new treatment option has been added to the arsenal, Afrezza Inhalation Powder. This week, the US Food and Drug Administration (FDA) approved the rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus, or Type I diabetes. The FDA estimates that 25.8 million people in...

2014-06-27 04:21:25

Pre-Settlement Case Funding Firm announces new program focus for plaintiffs of Byetta, as well as Actos, Januvia, and Victoza cases. LOS ANGELES, June 27, 2014 /PRNewswire/ -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, disclosed today a new lawsuit cash advance program that helps clients with cases facing Byetta complications. In 2011, after California medical researchers discovered that patients using Byetta are 3 times more at risk for Pancreatic cancer, the number of...

2014-06-26 08:28:04

Merkerson Visits Washington, D.C. on June 26 With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J., June 26, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and actress S. Epatha Merkerson are bringing the America's Diabetes Challenge: Get to Your Goals program to Washington, D.C. to encourage African Americans with type 2 diabetes to know their A1C -- their average blood sugar level over the past two to three...

2014-06-25 08:26:32

Dominique's Diabetes Dream Team gives insider tips to people with type 2 diabetes through a national campaign and his "Diabetes Coaches' Clipboard" PLAINSBORO, N.J., June 25, 2014 /PRNewswire/ -- Novo Nordisk is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with type 2 diabetes customize a full-court approach to managing the everyday challenges of the disease....

2014-06-23 16:24:44

--Microbiome Modulator NM504 Significantly Improved Blood Glucose Control and Other Metabolic Parameters in Patients with Prediabetes and Type 2 Diabetes-- CHICAGO and BROOMFIELD, Colo., June 23, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today presented positive results from a clinical trial of microbiome modulator NM504 in prediabetes and type 2 diabetes at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society....

2014-06-20 23:07:43

In light of Blue Cross and Blue Shield of Massachusetts’ recent Actos lawsuit, Flood Law Group announces it is investigating potential Actos claims. Washington, DC (PRWEB) June 20, 2014 Flood Law Group announces it is now available to investigate potential Actos claims after a recent lawsuit announcement by Blue Cross and Blue Shield of Massachusetts. The lawsuit was filed June 11, 2014. According to documents in case No. 6:14-cv-01159, Blue Cross and Blue Shield of Massachusetts is...

2014-06-17 08:28:54

- Recent Publication Shows Metformin Improves Glycemic Control by Modulating the Gut Microbiome and Triggering Specific Cellular and Immune Mechanisms - BROOMFIELD, Colo., June 17, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today reported that a recently published scientific study shows that the diabetes drug, metformin, alters the bacterial populations in the gut in favor of a bacterial species that exerts specific cellular and immunological effects, resulting...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related